This website uses cookies. For more information please contact us or consult our privacy policy.

Your binder contains too many pages, the maximum is 40.

We are unable to add this page to your binder, please try again later.

This page has been added to your binder.

Zak Megeed
Zak Megeed
Associate
San Francisco +1 415 591 7060 zmegeed@cov.com Download V-card

Zak Megeed advises life sciences companies across the full range of transactional matters, including strategic collaborations, licensing, acquisitions and divestitures, and a variety of commercial and clinical agreements.

As a patent attorney, former scientist, and former head of intellectual property at a leading antibody discovery company, Dr. Megeed brings a deep understanding of intellectual property and science to intellectual property-focused strategic transactions.

  • A pharmaceutical company, in a strategic collaboration for the development and commercialization of alternative scaffold-based therapeutics for the treatment of inflammatory diseases.
  • A pharmaceutical company, in connection with its collaboration with two other companies to develop and commercialize a companion diagnostic assay for the use of a drug for the treatment of breast cancer.
  • A diagnostics company, in collaborations with multiple therapeutic partners for the co-development of companion diagnostic assays for use with the partners’ pharmaceutical products.
  • A pharmaceutical company, in a strategic collaboration and financing for the development and commercialization of novel therapeutics for the treatment of metabolic disorders.
  • A pharmaceutical company, in a strategic collaboration with a biotechnology company for the development and commercialization of an antibody-drug conjugate.
  • A pharmaceutical company, in a multi-product collaboration with a platform company to identify and optimize drug candidates for a number of challenging targets.
  • A biotechnology company, in a strategic collaboration and out-licensing arrangement for a monoclonal antibody product in Phase IIb clinical trials for inflammatory indications.
  • A pharmaceutical company, in a strategic collaboration and in-license arrangement for the development and commercialization of a small molecule product in Phase II clinical trials for dermatological indications.
  • A technology company, in connection with supply agreements in the solar, semiconductor and hardware industries.
  • A specialty pharmaceutical company, in connection with its merger with two other companies to create a fully-integrated specialty biopharmaceutical company.
  • A pharmaceutical company, in a multi-product supply and distribution arrangement in Venezuela.
  • A pharmaceutical company, in a supply and distribution arrangement in several Middle Eastern countries.
  • A pharmaceutical company, in connection with the development of a form agreement for use in companion diagnostic collaborations.
  • An emerging pharmaceutical company, in a variety of strategic, commercial and clinical matters prior to and following establishment of its in-house legal group.
  • A pharmaceutical company, in a collaboration for the development of an assay to confirm the eradication of a virus from patients.

Previous Experience

  • Associate in the life sciences group of an international law firm   
  • Head of intellectual property at a leading therapeutic antibody discovery company